New data shared in a poster presentation during the 19th European Association of Dermato-Oncology (EADO) Congress DecisionDx-Melanoma demonstrated improved risk-stratification of MSS with low-risk ...
Please provide your email address to receive an email when new articles are posted on . At year 10, overall survival was 90.2% in the Mohs micrographic surgery group vs. 88.3% in the wide local ...
The new Sassun-Mayo staging system, which integrates tumor deposit and lymph node counts, improves prognostic accuracy for patients with colon cancer compared with the standard American Joint ...
The AJCC staging is based on three main characteristics defining the natural history of melanoma; namely the extent of the primary tumor (T), the absence or presence of regional lymph node metastasis ...
Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...
Tumor-informed circulating tumor DNA (TI-ctDNA) based molecular residual disease (MRD) detection and relapse risk for patients with stage II-IV melanoma in surgical remission: A single center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results